Detail: structure-based drug design of an anti-Alzheimer's compound

About us

C2D2 is supported by a Wellcome Trust ‘Institutional Strategic Support Fund’ award, and the University of York.

Through strategic support for research, training and public engagement, it will ensure that York continues to makes a significant, tangible and quantifiable contribution to reducing the burden imposed by chronic diseases and disorders.

Our strategy

Our strategy for success will be driven forward by investment in four areas:

  • fostering interdisciplinarity
  • innovation and translation
  • capacity building
  • strength from partnership

Through this investment, we will:

  • introduce a discipline hopping internship program to equip our best young scientists for leading roles in interdisciplinary research
  • ensure that our world leading established scientists, as well as early career colleagues, have the opportunity to pursue high risk but innovative research
  • fund innovation and translation through a peer reviewed pump priming award scheme
  • utilise existing and new cohorts (including overseas) to provide a 'natural laboratory' to underpin biomedical and health research
  • continue to nurture and strengthen local networks, while investing in a highly visible campaign to raise awareness, stimulate discussion and engage with critical friends across the international biomedical and health research community

Click to download

General enquiries

  • C2D2 Administrator
    Biology Q/109
    University of York
    York YO10 5DD

    +44 (0)1904 328876

    c2d2@york.ac.uk

Partners

Key contacts